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Results: Patients between ages 30 and 60 years with MetS diagnosis were included in
this study. 31 patients (41.9%) were male and 43 patients (58.9%) were female.
Patients were divided into 2 groups according to CIMT measurement: 35 patients with
CIMT 1,0 mm were at group 1 and 39 patients with CIMT<1,0 mm were at group 2.
There were difference only age and fasting blood glucose parameter among groups. In
the multi-varians analysis, age and fasting blood glucose related in CIMT values were
not statistically signiﬁcant (p>0.05). Additionally, the common effect of age and
fasting blood glucose variables on the CIMT values were not statistically signiﬁcant
(p¼0.241). The MPV level was signiﬁcantly higher in patients with CIMT 1,0 mm
than in patients with CIMT <1,0 mm (8.20.7 vs. 7.80.6 ﬂ; p¼0.01) (Figure 1).
Conclusıons: The risk of atherosclerosis could be shown with following the MPV
values in MetS patients. Therefore, our results suggest that MPV is an important
marker for early detecting the risk of atherosclerosis in patients with MetS. In our
study, we showed that this risk could be determined with a simple blood count. Risk
of atherosclerosis can be assessed by examining the values of MPV, without any
additional blood tests or radiological examination.Table 1
Group 1
CIMT 1,0 mm
(mean sd)
Group 2
CIMT<1,0 mm
(mean sd) P
Number of patients (n) 35 39
Age (years) 51.96.5 46.68.1 0.003
Gender (F/M, n) 23/12 19/20 0.16
BMI (kg/m2) 31.34.0
30 (25-42)
32.25.0
31 (26-46)
0.62
Waist circumference (cm) 102.19.7 104.210.6 0.38
HT [n(%)] 14(40.0) 15(38.4) 0.94
DM [n(%)] 15(42.9) 10(25.6) 0.08
Smoking [n(%)] 6(17.1) 9(23.0) 0.33
SBP (mmhg) 128.111.8
130 (100-160)
124.612.5
120 (110-160)
0.09
DBP (mmhg) 81.87.1
80 (60-100)
79.47.1
80 (70-100)
0.06
Fasting glucose (mg/dl) 114.424.7
109 (76-206)
106.130.3
101 (81-260)
0.02
HbA1c (%) 6.30.9 6.10.99 0.37
HDL-cholesterol (mg/dl) 44.111.2 39.512.7 0.10
LDL-cholesterol (mg/dl) 116.536.1 120.739.2 0.63
Triglyceride (mg/dl) 178.180.8 217.6108.9 0.08
Hemoglobin (g/dl) 13.31.2 13.61.4 0.23
Platelet (x109/l) 256.461.2 286.866.2 0.04
MPV (ﬂ) 8.20.7 7.80.6 0.01
Baseline characteristcs of patients (BMI: body mass index, HT: hypertension, DM: diabetes
mellitus, SBP: systolic blood pressure, DBP: diastolic blood pressure, LDL: low-density lipo-
protein, HDL: high-density lipoprotein, MPV: mean platelet volume
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Atherosclerosis is a systemic disease which effects large and medium sized arteries
besides coronary arteries. Atherosclerosis and associated diseases are the leading
cause of death all over the world. It is known that endothelial dysfunction already
starts before atherosclerotic involvement of coronary arteries. To diagnose athero-
sclerosis before organ damage has occured is important. The aim of the study is to
evaluate the relationship between endothelial dysfunction and serum endothelin-1
levels, small artery elasticity, coronary artery disease severity and also to seek an
answer if endothelin-1 antagonists may be beneﬁcal for cardiac Syndrome X or not.
Patients with chest pain were evaluated with exercise stress test or myocardial
perfusion scintigraphy. Then ischemia deteceted patients underwent elective coronary
angiography. Using ELISA method serum endothelin-1 levels of all patients were
measured and a radial artery tonometer was used to measure arterial elasticity of all
patients. The patients were grouped according to coronary artery disease history,
ischemia existence and coronary angiogram results. The groups were compared with
regards to serum endothelin-1 level, small artery elasticity and Gensini scores.
In the study group, 50 patients (62,5%) were male and 30 (37,5%) were female and
the average age was 58,4 10,7 years. Twenty six (32,5%) of the patients had
coronary artery disease history. Ischemia was present in 55 (68%) patients. Critical
coronary lesions were present in 21 (38%) patients who underwent coronary angi-
ography. Median serum endothelin-1 level was 18,9 ng/L (8,5-134,9 ng/L) in patients
with ischemia and 14,8 ng/L (8,4-41,5 ng/L) in patients without ischemia. Serum
endothelin-1 level of ischemic patients was higher (p¼0.045). There wasn't a statisti-
cally signiﬁcant relationship between serum endothelin- 1 levels and coronary artey
disease history, small artery elasticity, Gensini scores.
Because of serum endothelin-1 level of patients without coronary artery disease history
but with ischemia and normal coronary angiograms was higher than non-ischemic
patients, it is assumed that endothelin-1 antagonistsmaybebeneﬁcal for cardiacSyndrome
X. To support this, there is a need for large prospective population based studies.
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Background: It has been shown that low levels of 25-hydroxyvitamin D are asso-
ciated with increased cardiovascular risk factors and events. The relationship between
serum 25-hydroxyvitamin D level and in-stent stenosis was investigated in our study.
Methods: A total of 181 patients with stable coronary artery disease and previously
implanted (>3 months) bare-metal stent were included in the study. Two groups were
formed according to angiographic results as Group 1 (50% in-stent stenosis) and
Group 2 (<50% in-stent stenosis). Serum 25-hydroxyvitamin D measurements were
performed by reverse-phase HPLC.
Results: The mean serum 25-hydroxyvitamin D level was found to be signiﬁcantly
lower in Group 1 compared to Group 2 (17.75.3 ng/ml and 20.96.7 ng/ml, p<0.01,
respectively) and length of stent was longer in Group 1 compared to Group 2
(18.75.3 mm and 17.111.2 mm, p<0.01, respectively). In multivariate logistic
regression analysis, only low level of serum 25-hydroxyvitamin D was an independent
risk factor for in-stent stenosis (p<0.01, OR¼0.915, 95% CI 0.866-0.967).
Conclusıon: Our results suggest that lower levels of 25-hydroxyvitamin D are
associated with an increased risk of in-stent stenosis.
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Purpose: Our purpose was to investigate the relationship between the prevalence of
glucose intolerance and type 2 diabetes with cardiometabolic risk factors in patients
with asymptomatic coronary artery disease.
Methods: 132 patients who had not been previously diagnosed with glucose intol-
erance or diabetes, and had coronary artery disease (CAD) were enrolled. 2 hour
standard oral glucose tolerance test (OGTT) with 75 gr. glucose was conducted.
Patients were divided into two groups as normal and with impaired glucose tolerance
(IGT) or diabetes (DM). Groups were compared according to waist circumference,
body-muscle index, creatinin clearance, risk factors of CAD, severity of CAD,
functional capacity, angina score. In patients with Fasting plasma glucose (FPG)<100
mg/dl, HOMA-IR values were investigated. For statistical analysis, t-test, Mann-
Whitney U, Kruskal Wallis or logistic regression test were used.
Result: Prevelance of IGT(%26) or DM (%4) was %30 in patients with CAD. %27 of
patients had a value of FPG <100 mg/dl before the test was conducted. Between theERS C213
